NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/07/2025
Voltar para busca
Dado oficial do USPTO
TIDES WUXI TIDES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
29/07/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 40, 42
Data de depósito
27/04/2023
Data de registro
29/07/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/07/2025
Última transação
29/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
29/03/2023
Primeiro uso no comércio
17/04/2023
Código do desenho
3
Tipo de titular
16
Localização do titular
Shanghai, CN
Examinador
KETCHUM, BRENDAN
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Shanghai SynTheAll Pharmaceutical Co., Ltd
Representantes
Jonathan M. Rixen Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmentalbehavioral and neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin; Medicines for human purposesmedicines for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmentalbehavioral and neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Raw material medicinemedicines for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmentalbehavioral and neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin; Pharmaceutical preparationsfor the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmentalbehavioral and neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin; pharmaceutical preparationsantivirals; Chemico-pharmaceutical preparations for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseases; Biological preparations for medical purposes for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseases; Chemical preparations for the diagnosis of pregnancy; Chemical preparations for pharmaceutical or medical purposesfor the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmentalbehavioral and neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin; Chemical preparations for medical purposeschemical reagents for medical purposes; Chemical preparations for medical purposes; Diagnostic preparations for medical purposes; Nutritional supplements; Drugs for medical purposes; Reagent paper for medical purposes; Medical reagents; Disinfectants for hygiene purposes; Cultures of microorganisms for medical use; Biomedicine; Adjuvants for medical purposes; Vaccines; Veterinary preparations
Classe 40
Metal treating; Material treatment information; Processing and handling of chemical reagentstreatment of materials in the nature of chemicals; Cloth treating; Paper treating; Processing of oil; Stripping finishestreatment of wood for preservation purposes; Recycling of waste and trash; Air purification; Processing of medicinal materials being material treatment services in connection with recycling; Cryopreservation services; Providing information relating to material treatment; Custom assembling of materials for others being custom manufacture of pharmaceuticalschemotherapy drugsantibiotic medicinesvaccines by pharmaceutical compounders; Processing of biomedical materials for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Customized production service being custom manufacturing of pharmaceuticals; Custom manufacture of pharmaceuticals medical preparation
Classe 42
Computer programming; Material testing; Technical research in the field of pharmaceutical studies; Research and development of new products for others; Technology consultancy in the field of cybersecurity; Chemical analysis; Chemistry serviceschemistry consultation; Chemical research; Biological research; conducting clinical trials for othersbeing for scientific and medical research; Quality checking and testingquality control for others; Scientific laboratory services; Genome structure and function analysis; Gene screeningDNA screening for scientific research purpose; Biomedical research services; Stem cell research service; Drug research and development servicespharmaceutical research; cell culture services for scientific research purposesfor others; Design and development of computer hardware and software; Development and creation of computer programs for data processing; Computer programming in the field of medical treatment; Product quality testing; assessment of quality of products; Scientific research; Surveying; Bacteriological research; The designproduction in the nature of designmaintenance of a computer program; Computer software design; Computer technology consultancy in the field of engineering; Information technology consulting relating to computer network design; Artificial intelligence technology consulting; Research on artificial intelligence technology; Research and development of new products; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Drug evaluationpharmaceutical product evaluation; Vaccine research and development services; Cancer medicine research; Biotechnology research; Drug testing being testing of pharmaceuticals; Pharmaceutical research; Cancer scientific research for medical purposes; Development and Testing of Chemical production methods; Implementation of early evaluation in the field of new drugsproduct quality testing; Biochemical research and analysis; Chemical analysis evaluation service; Chemical synthesis evaluation service; scientific research of the mode of action of chemical combinations on animals
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/07/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/06/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
22/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/01/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
22/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/01/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/07/2024
IUAF
USE AMENDMENT FILED
30/04/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2024
PUBO
PUBLISHED FOR OPPOSITION
05/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/01/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/01/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
05/01/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/01/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/01/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/01/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2023
GNRT
NON-FINAL ACTION E-MAILED
07/11/2023
CNRT
NON-FINAL ACTION WRITTEN
07/11/2023
DOCK
ASSIGNED TO EXAMINER
28/10/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
26/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/05/2023
NWAP
NEW APPLICATION ENTERED
01/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TIDES WUXI TIDES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.